Bochem Parenteral Private Limited - Due diligence report

A 360° intelligence report on Bochem Parenteral Private Limited: trust score, financial health, credit view, compliance, directors, growth a…

2014-03-25 Ujjain, Madhya Pradesh Active Unlisted Active Non-Compliant
Share
BP Bochem Parenteral Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bochem Parenteral Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Bochem Parenteral Private Limited is assessed as Moderate with a Trust Score of 72/100. Bochem Parenteral Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 23 Jul 2026 from the latest processed filings. Bochem Parenteral Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (2.00 cr) · 1 satisfied (6.50 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Union Bank Of India1 48.0 cr
Others1 48.0 cr
Compliance Score: 55/100 Moderate
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2018 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
Balaji Seethamsetty 01234567 Director 01/04/2018 6 yrs Approved
SUNIL JAIN 01234567 Director 01/04/2018 6 yrs Approved
MILIND ARVIND GOKHALE 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 70
Growth signals & trust indicators
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
Operating for 12+ years.
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
Statutory filings appear overdue.
Compliance score is weak (55/100).
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence65/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 2.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
24 Dec 2024
Director appointed
Balaji Seethamsetty (Additional Director)
16 Mar 2020
Director appointed
MILIND ARVIND GOKHALE (Additional Director)
Director ceased
VIKAS KUMAR JAIN
30 Sep 2018
Last AGM held
Annual general meeting
31 Mar 2018
Latest balance sheet
Filed with ROC
31 Oct 2017
Charge created
Others - 2.00 cr
13 Oct 2017
Charge satisfied
Union Bank Of India
28 Dec 2015
Director ceased
MILIND ARVIND GOKHALE
05 Nov 2015
Charge created
Union Bank Of India - 6.50 cr
25 Mar 2014
Incorporated
Registered with Roc Gwalior
Director appointed
SUNIL JAIN (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2016 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Kotrishyam Traders Private Limited U51109RJ2013PTC044213 Bhilwara, Rajasthan, India
Triton Mining & Minerals India Private Limited U15100MP2015PTC034546 Indore, Madhya Pradesh, India
Konark Global Private Limited U28112CT2013PTC000959 Raipur, Chattisgarh, India
Asian Books Private Limited U74899DL1988PTC033079 New Delhi, Delhi, India
Mahi Corporation Private Limited U51909GJ2013PTC076785 Rajkot, Gujarat, India
Skv Exim Private Limited U51311RJ2011PTC037161 Bhilwara, Rajasthan, India
Eklavya Impex Private Limited U74999MH2011PTC217619 Mumbai, Maharashtra, India
Akana Estate Private Limited U68100GJ2011PTC063473 Surat City, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bochem Parenteral Private Limited before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bochem Parenteral Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Bochem Parenteral Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Bochem Parenteral Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Bochem Parenteral Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bochem Parenteral Private Limited an active company?

Bochem Parenteral Private Limited has MCA status “Active” with a compliance score of 55/100 (Moderate).

Is Bochem Parenteral Private Limited financially healthy?

Bochem Parenteral Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Bochem Parenteral Private Limited?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bochem Parenteral Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Bochem Parenteral Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Bochem Parenteral Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 55/100 (Moderate).

Is it risky to lend to Bochem Parenteral Private Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.